Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | UBE2N | P61088 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3168782 | 1.00 | LMNA (0.41) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL6448213 | 1.00 | LMNA (0.41) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL2985499 | 1.00 | LMNA (0.41) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL151903 | 0.97 | LMNA (0.40) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL24176357 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL5482067 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL4006613 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL21552219 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL21552377 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN | |
| SCHEMBL15848372 | 0.91 | TRPV1 (0.46) | LMNACYP2D6SPHK1CYP3A4GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4621488-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | Ycchem Co., Ltd. (KR) | 2025-09-24 | — | — | EP | claimed |
| US-20250236813-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | YCCHEM CO., LTD. (KR) | 2025-07-24 | — | — | US | claimed |
| US-20230266672-A1 | PROCESS SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | YOUNG CHANG CHEMICAL CO., LTD (KR) | 2023-08-24 | — | — | US | claimed |
| EP-4212958-A1 | PROCESS SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | Young Chang Chemical Co., Ltd. (KR) | 2023-07-19 | — | — | EP | claimed |
| CN-116097398-A | Process liquid composition for extreme ultraviolet lithography and pattern forming method using the same | 荣昌化学制品株式会社 | 2023-05-09 | — | — | CN | claimed |
| US-20220342313-A1 | PROCESS LIQUID COMPOSITION FOR PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | YOUNG CHANG CHEMICAL CO., LTD (KR) | 2022-10-27 | — | — | US | claimed |
| EP-4036648-A1 | PROCESS LIQUID COMPOSITION FOR PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | Young Chang Chemical Co., Ltd. (KR) | 2022-08-03 | — | — | EP | claimed |
| CN-114450640-A | Process liquid composition for lithography and pattern formation method using the same | 荣昌化学制品株式会社 | 2022-05-06 | — | — | CN | claimed |
| WO-2022055128-A1 | PROCESS SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | 영창케미칼 주식회사 | 2022-03-17 | — | — | WO | claimed |
| WO-2021060672-A1 | PROCESS LIQUID COMPOSITION FOR PHOTOLITHOGRAPHY AND PATTERN FORMING METHOD USING SAME | 영창케미칼 주식회사 | 2021-04-01 | — | — | WO | claimed |
| US-20250368983-A1 | CONTROLLING FOR TAGMENTATION SEQUENCING LIBRARY INSERT SIZE USING ARCHAEAL HISTONE-LIKE PROTEINS | KAPA BIOSYSTEMS INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4621488-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | Ycchem Co., Ltd. (KR) | 2025-09-24 | — | — | EP | disclosed |
| US-20250236813-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | YCCHEM CO., LTD. (KR) | 2025-07-24 | — | — | US | disclosed |
| EP-4581153-A1 | IMPROVEMENTS TO NEXT-GENERATION TARGET ENRICHMENT PERFORMANCE | F. Hoffmann-La Roche AG (CH) | 2025-07-09 | — | — | EP | disclosed |
| US-20250206939-A1 | CURABLE SULFONATED POLYMER COMPOSITIONS | NOTARK CORPORATION (US) | 2025-06-26 | — | — | US | disclosed |
| US-20030147926-A1 | Compositions and methods for transdermal oxybutynin therapy | WATSON PHARMACEUTICALS, INC. | 2003-08-07 | — | — | US | disclosed |
| US-5320715-A | Separation of 1-pentanol from cyclopentanol by extractive distillation | Berg, Lloyd (US) | 1994-06-14 | — | — | US | disclosed |
| US-5021507-A | Arcylic modified reactive urethane hot melt adhesive compositions | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
| EP-0246473-B1 | ACRYLIC MODIFIED REACTIVE URETHANE HOT MELT ADHESIVE COMPOSITIONS | National Starch and Chemical Corporation (US) | 1990-04-18 | — | — | EP | disclosed |
| EP-0246473-A1 | Acrylic modified reactive urethane hot melt adhesive compositions | National Starch and Chemical Corporation (US) | 1987-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030147926-A1 | Compositions and methods for transdermal oxybutynin therapy | CHRNB1, CYP1B1, OXER1 | LMNA 3621/4885CYP2D6 22/4885SPHK1 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.